China Medical System to pay Insilico up to about $177 million for central nervous system work
13/07/2026 02:53
China Medical System to pay Insilico up to about $177 million for central nervous system work SHANGHAI, July 13 (Reuters) - Chinese drugmaker China Medical System 0867.HK will pay Insilico Medicine 03696.HK up to about 1.2 billion yuan ($177 million) in payments linked to milestones for work on a research and development programme in the central nervous system disease field, the Boston-based drug discovery firm said.
(Reporting by Andrew Silver in Shanghai; Editing by Jacqueline Wong)
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7